GlaxoSmithKline PLC (NYSE:GSK)

42.53
Delayed Data
As of Oct 18
 +0.06 / +0.14%
Today’s Change
36.41
Today|||52-Week Range
43.22
+11.31%
Year-to-Date
Better Buy: GlaxoSmithKline vs. Merck
Oct 15 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close42.47
Today’s open42.52
Day’s range42.37 - 42.64
Volume1,428,142
Average volume (3 months)2,283,498
Market cap$106.1B
Data as of 6:30pm ET, 10/18/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)-6.95%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+5.72%
P/E ratio18.4
Price/Sales2.31
Price/Book18.85

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.18+0.17%
ABBVAbbVie+1.32+1.76%
AZNAstraZeneca-0.26-0.59%
SNYSanofi-0.33-0.71%
Data as of 6:30pm ET, 10/18/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$0.80
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Brentford, Greater London

Forecasts